Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guilherme Rabinowits

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
Oncotargets and Therapy|October 17, 2017
Is this the end of cytotoxic chemotherapy in Merkel cell carcinoma?Guilherme Rabinowits
Cancers|May 21, 2014
Systemic Therapy for Merkel Cell Carcinoma: What's on the Horizon?Guilherme Rabinowits
Frontiers in Oncology|May 25, 2026
Head and neck cancer therapeutic vaccines: a reviewAbigail Huetteman, Guilherme Rabinowits
The Journal of the Kentucky Medical Association|May 8, 2009
Bladder cancer: clinical practiceGuilherme Rabinowits, Damian A Laber
Oral Oncology|July 31, 2012
Overcoming resistance to EGFR inhibitor in head and neck cancer: a review of the literatureGuilherme Rabinowits, Robert I Haddad
International Journal of Radiation Oncology, Biology, Physics|December 20, 2017
Consider Surgery, but Not in This CaseGuilherme Rabinowits, Charles Yoon, Manisha Thakuria
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 27, 2014
Update on the biology and clinical management of Merkel cell carcinomaManisha Thakuria, Nicole R LeBoeuf, Guilherme Rabinowits
The Oncologist|November 23, 2023
Head and Neck Squamous Cell Carcinoma of Unknown Primary: A Diagnostic Work-UpMeenakkshy Manoharan, Noah S Kalman, Guilherme Rabinowits
Current Treatment Options in Oncology|September 22, 2014
Human papillomavirus-associated oropharynx cancer (HPV-OPC): treatment optionsNicole G Chau, Guilherme Rabinowits, Robert I Haddad
Anti-Cancer Drugs|September 23, 2003
Fatal pulmonary toxicity in a patient treated with gefitinib for non-small cell lung cancer after previous hemolytic-uremic syndrome due to gemcitabineGuilherme Rabinowits, Daniel Herchenhorn, Milton Rabinowits, et al.
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Oncotargets and Therapy|October 17, 2017
Is this the end of cytotoxic chemotherapy in Merkel cell carcinoma?Guilherme Rabinowits
Cancers|May 21, 2014
Systemic Therapy for Merkel Cell Carcinoma: What's on the Horizon?Guilherme Rabinowits
Frontiers in Oncology|May 25, 2026
Head and neck cancer therapeutic vaccines: a reviewAbigail Huetteman, Guilherme Rabinowits
The Journal of the Kentucky Medical Association|May 8, 2009
Bladder cancer: clinical practiceGuilherme Rabinowits, Damian A Laber
Oral Oncology|July 31, 2012
Overcoming resistance to EGFR inhibitor in head and neck cancer: a review of the literatureGuilherme Rabinowits, Robert I Haddad
International Journal of Radiation Oncology, Biology, Physics|December 20, 2017
Consider Surgery, but Not in This CaseGuilherme Rabinowits, Charles Yoon, Manisha Thakuria
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 27, 2014
Update on the biology and clinical management of Merkel cell carcinomaManisha Thakuria, Nicole R LeBoeuf, Guilherme Rabinowits
The Oncologist|November 23, 2023
Head and Neck Squamous Cell Carcinoma of Unknown Primary: A Diagnostic Work-UpMeenakkshy Manoharan, Noah S Kalman, Guilherme Rabinowits
Current Treatment Options in Oncology|September 22, 2014
Human papillomavirus-associated oropharynx cancer (HPV-OPC): treatment optionsNicole G Chau, Guilherme Rabinowits, Robert I Haddad
Anti-Cancer Drugs|September 23, 2003
Fatal pulmonary toxicity in a patient treated with gefitinib for non-small cell lung cancer after previous hemolytic-uremic syndrome due to gemcitabineGuilherme Rabinowits, Daniel Herchenhorn, Milton Rabinowits, et al.
Pageof 6